Insider · CIK 0001662520

Castellanos Elaine

Reports to the SEC for 1 company · IRVING, TX

sec.gov

Transactions

Companies

Filings

CIK

0001662520

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-06-09	REATA PHARMACEUTICALS INCS Sale	VP, Chief Accounting Officer	SSale	−554 sh	$142.50	−$78.9K	14,546
2021-06-09	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−8,454 sh	—	—	9,934
2021-06-09	REATA PHARMACEUTICALS INCClass B common stockM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+8,454 sh	$22.57	+$191K	8,454
2021-06-09	REATA PHARMACEUTICALS INCClass B common stockC Conversion	VP, Chief Accounting Officer	CConversion	−8,454 sh	—	—	0
2021-06-09	REATA PHARMACEUTICALS INCS Sale	VP, Chief Accounting Officer	SSale	−7,900 sh	$141.86	−$1.12M	15,100
2021-06-09	REATA PHARMACEUTICALS INCC Conversion	VP, Chief Accounting Officer	CConversion	+8,454 sh	—	—	23,000
2021-06-07	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−1,546 sh	—	—	18,388
2021-06-07	REATA PHARMACEUTICALS INCS Sale	VP, Chief Accounting Officer	SSale	−636 sh	$147.16	−$93.6K	14,546
2021-06-07	REATA PHARMACEUTICALS INCS Sale	VP, Chief Accounting Officer	SSale	−910 sh	$146.47	−$133K	15,182
2021-06-07	REATA PHARMACEUTICALS INCC Conversion	VP, Chief Accounting Officer	CConversion	+1,546 sh	—	—	16,092
2021-06-07	REATA PHARMACEUTICALS INCClass B common stockC Conversion	VP, Chief Accounting Officer	CConversion	−1,546 sh	—	—	0
2021-06-07	REATA PHARMACEUTICALS INCClass B common stockM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+1,546 sh	$22.57	+$34.9K	1,546
2021-05-26	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−7,066 sh	—	—	19,934
2021-05-26	REATA PHARMACEUTICALS INCClass B common stockC Conversion	VP, Chief Accounting Officer	CConversion	−10K sh	—	—	0
2021-05-26	REATA PHARMACEUTICALS INCClass B common stockM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+2,934 sh	$11.00	+$32.3K	2,934
2021-05-26	REATA PHARMACEUTICALS INCC Conversion	VP, Chief Accounting Officer	CConversion	+10K sh	—	—	24,546
2021-05-26	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−2,934 sh	—	—	0
2021-05-26	REATA PHARMACEUTICALS INCClass B common stockM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+7,066 sh	$22.57	+$159K	10,000
2021-05-26	REATA PHARMACEUTICALS INCS Sale	VP, Chief Accounting Officer	SSale	−10K sh	$124.55	−$1.25M	14,546
2021-01-04	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	VP, Chief Accounting Officer	AAward	+8,000 sh	—	—	8,000
2020-11-18	REATA PHARMACEUTICALS INCG Gift	VP, Chief Accounting Officer	GGift	−600 sh	—	—	14,546
2020-11-12	REATA PHARMACEUTICALS INCClass B common stockM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+3,500 sh	$11.00	+$38.5K	3,500
2020-11-12	REATA PHARMACEUTICALS INCClass B common stockC Conversion	VP, Chief Accounting Officer	CConversion	−3,500 sh	—	—	0
2020-11-12	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−3,500 sh	—	—	2,934
2020-11-12	REATA PHARMACEUTICALS INCS Sale	VP, Chief Accounting Officer	SSale	−3,500 sh	$176.02	−$616K	15,146
2020-11-12	REATA PHARMACEUTICALS INCC Conversion	VP, Chief Accounting Officer	CConversion	+3,500 sh	—	—	18,646
2020-06-01	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−2,000 sh	—	—	6,434
2020-06-01	REATA PHARMACEUTICALS INCS Sale	VP, Chief Accounting Officer	SSale	−2,000 sh	$143.97	−$288K	15,146
2020-06-01	REATA PHARMACEUTICALS INCC Conversion	VP, Chief Accounting Officer	CConversion	+2,000 sh	—	—	17,146
2020-06-01	REATA PHARMACEUTICALS INCClass B common stockC Conversion	VP, Chief Accounting Officer	CConversion	−2,000 sh	—	—	0
2020-06-01	REATA PHARMACEUTICALS INCClass B common stockM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+2,000 sh	$11.00	+$22K	2,000
2020-03-02	REATA PHARMACEUTICALS INCClass B common stockC Conversion	VP, Chief Accounting Officer	CConversion	−2,000 sh	—	—	0
2020-03-02	REATA PHARMACEUTICALS INCClass B common stockM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+2,000 sh	$11.00	+$22K	2,000
2020-03-02	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−2,000 sh	—	—	8,434
2020-03-02	REATA PHARMACEUTICALS INCS Sale	VP, Chief Accounting Officer	SSale	−2,000 sh	$194.32	−$389K	15,146
2020-03-02	REATA PHARMACEUTICALS INCC Conversion	VP, Chief Accounting Officer	CConversion	+2,000 sh	—	—	17,146
2020-01-02	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	VP, Chief Accounting Officer	AAward	+15K sh	—	—	15,000
2019-12-02	REATA PHARMACEUTICALS INCClass B common stockM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+2,000 sh	$11.00	+$22K	2,000
2019-12-02	REATA PHARMACEUTICALS INCClass B common stockC Conversion	VP, Chief Accounting Officer	CConversion	−2,000 sh	—	—	0
2019-12-02	REATA PHARMACEUTICALS INCC Conversion	VP, Chief Accounting Officer	CConversion	+2,000 sh	—	—	17,146
2019-12-02	REATA PHARMACEUTICALS INCS Sale	VP, Chief Accounting Officer	SSale	−2,000 sh	$194.24	−$388K	15,146
2019-12-02	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−2,000 sh	—	—	10,434
2019-10-28	REATA PHARMACEUTICALS INCClass B common stockM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+4,000 sh	$11.00	+$44K	4,000
2019-10-28	REATA PHARMACEUTICALS INCClass B common stockC Conversion	VP, Chief Accounting Officer	CConversion	−4,000 sh	—	—	0
2019-10-28	REATA PHARMACEUTICALS INCS Sale	VP, Chief Accounting Officer	SSale	−4,000 sh	$200.00	−$800K	15,146
2019-10-28	REATA PHARMACEUTICALS INCC Conversion	VP, Chief Accounting Officer	CConversion	+4,000 sh	—	—	19,146
2019-10-28	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−4,000 sh	—	—	12,434
2019-10-25	REATA PHARMACEUTICALS INCClass B common stockC Conversion	VP, Chief Accounting Officer	CConversion	−3,213 sh	—	—	0
2019-10-25	REATA PHARMACEUTICALS INCC Conversion	VP, Chief Accounting Officer	CConversion	+3,213 sh	—	—	15,146
2019-10-25	REATA PHARMACEUTICALS INCC Conversion	VP, Chief Accounting Officer	CConversion	+2,000 sh	—	—	17,146

Recent filings

Accepted (ET)
Jun 94
Castellanos Elaine0001209191-21-039175
SEC(opens sec.gov)
May 274
Castellanos Elaine0001209191-21-036326
SEC(opens sec.gov)
Jan 64
Castellanos Elaine0001209191-21-001998
SEC(opens sec.gov)

Companies

REATA PHARMACEUTICALS INCVP, Chief Accounting Officer

Address

2801 GATEWAY DRIVE, SUITE 150

IRVING, TX, 75063